Published on 17 Jan 2022 on Insider Monkey via Yahoo Finance

10 Healthcare Stocks to Buy According to Billionaire DE Shaw

Article preview image

In this article, we discuss the 10 healthcare stocks to buy according to billionaire DE Shaw based on Q3 holdings of his fund. If you want to skip our detailed analysis of Shaw’s history, investment philosophy, and hedge fund performance, go directly to the 5 Healthcare Stocks to Buy According to Billionaire DE Shaw.

David Elliot Shaw is a wealthy American scientist and hedge fund manager. Shaw received a bachelor's degree summa cum laude from the University of California, San Diego, and a Ph.D. from Stanford University in 1980 before joining Columbia University's computer science department as an assistant professor. Shaw made his fortune by utilizing cutting-edge high-speed computer networks to exploit inefficiencies in financial markets.

D E Shaw is a New York-based worldwide investment management hedge fund created in 1988 by David E. Shaw. It is one of the oldest hedge funds and one of the first to apply complicated mathematical trading algorithms. In 1996, Fortune magazine called the billionaire "King Quant" for his hedge fund’s pioneering role in high-speed quantitative trading.

NASDAQ.CERN price evolution
NYSE.TMO price evolution
NYSE.CAH price evolution
NYSE.TFC price evolution
NYSE.MDT price evolution
NASDAQ.ILMN price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Hot Job Market, Strong Demand for CFOs Strain Due Diligence

Mr. Meline will stay on as CFO while Moderna searches for Mr. Gomez’s permanent replacement. Stro...

The Wall Street Journal 12 May 2022

Moderna CFO lasts one day on job after probe at former company

Moderna Inc. Chief Financial Officer Jorge Gomez left the Covid-19 vaccine maker after just one d...

Stamford Advocate 11 May 2022

LaserShip Announces Scott Nelson as Chief Operating Officer

Nelson comes to LaserShip as an industry leader with a record of success in supply chain operatio...

WFMZ Eastern Pennsylvania and Western New Jersey 9 May 2022

AG announces $518 million settlement from pharmaceutical companies over their role in opioid crisis...

The Washington Attorney General’s trial against McKesson Corp., Cardinal Health Inc. and...

Bellevue Reporter 9 May 2022

McKesson Corp. stock falls Monday, still outperforms market

Shares of McKesson Corp. slipped 2.25% to $326.47 Monday, on what proved to be an all-around dism...

Market Watch 9 May 2022

7 Stock Picks to Play the Post-Pandemic Return of Dental Visits

Now that the country looks more normal than ever since the start of the pandemic, people need to ...

InvestorPlace via Yahoo Finance 9 May 2022

Cardinal Health has no plans to divest struggling medical supply business, CEO Mike Kaufmann says

Analysts were uncharacteristically blunt in Cardinal Health Inc.'s quarterly conference call...

American City Business Journals 5 May 2022

Analyst Report: Cardinal Health, Inc.

Cardinal Health is a leading pharmaceutical wholesaler, engaged in the sourcing and distribution ...

Morningstar Research via Yahoo Finance 5 May 2022

Cardinal Health's stock falls 6% after earnings miss

Shares of Cardinal Health Inc. tumbled 6.0% in premarket trading on Thursday after the medical an...

Market Watch 5 May 2022

WA attorney general announces $518M proposed settlement agreement with 3 opioid distributors

Ferguson filed a civil lawsuit in 2019 in King County Superior Court against three drug-distribut...

Seattle Times 3 May 2022